Abstract

Host cell factors can either positively or negatively regulate the assembly and egress of HIV-1 particles from infected cells. Recent reports have identified a previously uncharacterized transmembrane protein, tetherin/CD317/BST-2, as a crucial host restriction factor that acts during a late budding step in HIV-1 replication by inhibiting viral particle release. Although tetherin has been shown to promote the retention of nascent viral particles on the host cell surface, the precise molecular mechanisms that occur during and after these tethering events remain largely unknown. We here report that a RING-type E3 ubiquitin ligase, BCA2 (Breast cancer-associated gene 2; also called Rabring7, ZNF364 or RNF115), is a novel tetherin-interacting host protein that facilitates the restriction of HIV-1 particle production in tetherin-positive cells. The expression of human BCA2 in “tetherin-positive” HeLa, but not in “tetherin-negative” HOS cells, resulted in a strong restriction of HIV-1 particle production. Upon the expression of tetherin in HOS cells, BCA2 was capable of inhibiting viral particle production as in HeLa cells. The targeted depletion of endogenous BCA2 by RNA interference (RNAi) in HeLa cells reduced the intracellular accumulation of viral particles, which were nevertheless retained on the plasma membrane. BCA2 was also found to facilitate the internalization of HIV-1 virions into CD63+ intracellular vesicles leading to their lysosomal degradation. These results indicate that BCA2 accelerates the internalization and degradation of viral particles following their tethering to the cell surface and is a co-factor or enhancer for the tetherin-dependent restriction of HIV-1 release from infected cells.

Highlights

  • The human immunodeficiency virus (HIV) exploits the host cell machinery to maximize viral particle production [1]

  • In tetherin-negative cells, viral particle release is much less affected by either the presence or absence of Viral Protein U (Vpu) [6,7]. These results suggest that Vpu antagonizes the function of tetherin, which otherwise restricts the release of HIV-1 from infected host cells

  • We have identified a RING-type E3 ubiquitin ligase, BCA2, which colocalizes and interacts with tetherin in human cells

Read more

Summary

Introduction

The human immunodeficiency virus (HIV) exploits the host cell machinery to maximize viral particle production [1]. Tetherin has been shown to block the release of lentiviruses such as HIV-1 or SIV, and other viruses such as MLV, HTLV-1, Lassa virus and the Marburg virus [8,9,10]. These results indicate that tetherin has broad antiviral properties through the inhibition of viral particle release, and that the activation of this protein might be an effective strategy as an antiviral therapy

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call